Mitsubishi UFJ Asset Management
SNNA

Mitsubishi UFJ Asset Management’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,820
Closed -$16K – 1006
2019
Q1 		$16K Hold
6,820
– – ﹤0.01% 923
2018
Q4 		$17K Buy
+6,820
New +$60.1K ﹤0.01% 915

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mitsubishi UFJ Asset Management's SNNA Position: Q2 2019 in Review

Mitsubishi UFJ Asset Management sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2019, closing a stake of 6,820 shares — an estimated $16K sold.

Mitsubishi UFJ Asset Management first reported a position in SNNA in Q4 2018 and held it in 2 quarters. The position peaked at $17K in Q4 2018. 48 funds tracked by Wall St. Rank hold SNNA as of Q2 2019.

  • Mitsubishi UFJ Asset Management reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 6,820 Sienna Biopharmaceuticals, Inc. shares in Q2 2019, an estimated $16K.
  • Mitsubishi UFJ Asset Management first reported a position in Sienna Biopharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Mitsubishi UFJ Asset Management's Sienna Biopharmaceuticals, Inc. position peaked at $17K in Q4 2018.
  • 48 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2019.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.